Cargando…
Clinical Review: Gene-based therapies for ALI/ARDS: where are we now?
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) confer substantial morbidity and mortality, and have no specific therapy. The accessibility of the distal lung epithelium via the airway route, and the relatively transient nature of ALI/ARDS, suggest that the disease may be amen...
Autores principales: | Devaney, James, Contreras, Maya, Laffey, John G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218971/ https://www.ncbi.nlm.nih.gov/pubmed/21699743 http://dx.doi.org/10.1186/cc10216 |
Ejemplares similares
-
Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?
por: Curley, Gerard, et al.
Publicado: (2011) -
Anticytokine therapy for periodontal diseases: Where are we now?
por: Waykole, Yogesh Prakash, et al.
Publicado: (2009) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Novel Interventional Approaches for ALI/ARDS: Cell-Based Gene Therapy
por: Zhu, Ying-Gang, et al.
Publicado: (2011) -
Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)